Regenxbio (RGNX) Earnings
|
Expand Research on RGNX
| Next EPS Date | 5/1/24 | EPS Growth Rate | +17.6% |
|---|---|---|---|
| Average EPS % Beat Rate | -14.7% | Revenue Growth Rate | +22.9% |
| Average % Move 1-Wk after EPS | +3.2% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/1/24 | Q124 | N/A | -$1.26 | N/A | N/A | $23.52M | N/A | N/A | N/A | ||
| 2/28/24 | Q423 | N/A | -$1.26 | N/A | N/A | $35.6M | N/A | N/A | N/A | ||
| 11/8/23 | Q323 | -$1.41 | -$1.45 | +$0.04 | $28.91M | $26.26M | N/A |  | | Details | |
| 8/2/23 | Q223 | -$1.66 | -$1.19 | -$0.47 | $19.97M | $34.5M | N/A | | | Details | |
| 5/3/23 | Q123 | -$1.53 | -$1.38 | -$0.15 | $19.14M | $31.97M | N/A | | | Details | |
| 2/28/23 | Q422 | -$1.38 | -$1.24 | -$0.14 | $31.35M | $39.41M | N/A | | | Details | |
| 3/1/23 | Q422 | N/A | -$1.24 | N/A | N/A | $39.41M | N/A | N/A | N/A | ||
| 11/3/22 | Q322 | -$1.37 | -$1.42 | +$0.05 | $30.77M | $32.21M | N/A | | | Details |
